MedPath

Wrist Worn Trackers for monitoring activity in brain tumour patients

Phase 2
Recruiting
Conditions
Primary and secondary brain tumours
Cancer
High-grade glioma (HGG) Low-grade glioma (LGG) Metastatic brain cancer
Registration Number
ISRCTN34351424
Lead Sponsor
Imperial College NHS Healthcare Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

1. Primary or secondary brain tumours recently diagnosed and about to start treatment (unless matched healthy volunteers)
2. Patients with histology or clinically proven primary or secondary tumours who are fit to have radical treatment including surgery, radiotherapy or chemotherapy (unless matched healthy volunteers)
3. If being treated for recurrent tumour then at least 6 months must have elapsed since the completion of previous treatment (unless matched healthy volunteers)
4. Able to provide written informed consent
5. Fluent in English
6. Willing to undertake trial-specific measures, including wearing of and upload of data from wristband.
7. Aged over 18 years and 90 years or under

Patients do not need a smart phone to be eligible for this study

Exclusion Criteria

1. Patient undergoing WBRT
2. Patients with poor PS (PS3, 4) undergoing palliative treatments
3. Patients who have recently completed treatment (within 6 months) for primary or metastatic brain tumour

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath